|
Our Strategy for Creating Value |
- Develop and grow the market for AdnaGen diagnostic kits to build near-term revenues
- Utilize our capabilities to cost effectively develop drugs that have previously shown activity in cancer patients, albeit at a level which was not adequate to gain marketing approval
- We intend to in-license two additional clinical-stage drug candidates in the next 12-18 months
- Establish partnerships with other drug companies interested in using our technology to expedite their drug development efforts
- Enter into marketing agreements in order to commercialize our drugs and generate revenues through fees, milestone payments and royalties on sales
|
